Mid and small-caps look expensive: Should you rebalance your portfolio as earnings could lift equities from October?

OmniScience Capital suggests that Indian equities may see a re-rating in the second half of FY27 as corporate earnings improve. However, the firm warns that mid- and small-cap stocks are currently overvalued, advising investors to focus on selective stock picking rather than broad market exposure.
Why it matters
Investors are currently navigating a market consolidation phase, and understanding valuation gaps is critical for managing risk in Indian equity portfolios.
Indian equities could be heading for a re-rating as corporate earnings are expected to improve in the second half (H2) of the financial year and domestic institutional investors continue to support the market, according to Omniscience Capital.H2 refers to the second half of FY27, covering October 2026 to March 2027.However, investors may need to be more selective, particularly in the mid- and small-cap segments, where valuations remain elevated,For investors with significant exposure to these segments, the key question is whether the current valuations leave enough room for future returns or whether portfolios need to be reassessed.Are mid- and small-caps still expensive?Omniscience Capital points to a valuation gap across market-cap segments. While the broader market remains in a consolidation phase, pockets of small- and mid-caps remain overvalued. Consolidation is a period when markets move within a relatively narrow range without a clear upward or downward trend.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in